Entera Bio (ENTX) PT Raised to $14 at B.Riley
Tweet
Share
E-mailGet Alerts ENTX Hot Sheet
Price: $2.89 -0.34%
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
5 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
B.Riley analyst Kalpit Patel raised the price target on Entera Bio (NASDAQ: ENTX) to $14.00 (from $9.00) while maintaining a Buy rating.
You May Also Be Interested In
- Entera Bio names Riccardo Camisasca as chief medical officer
- DeFi Technologies (DEFT) PT Lowered to $1 at Benchmark Following Q2 Miss
- CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
